Literature DB >> 31714307

Postmastectomy Radiation Therapy on Permanent Implants or Tissue Expanders: Which is Better?

Alex M Lin1, Joani M Christensen1, Eric C Liao1, Curtis L Cetrulo1, Barbara L Smith2, William G Austen1, Jonathan Winograd1, Amy S Colwell1.   

Abstract

OBJECTIVES: This study evaluates complications and reconstructive failure rates in implant-based reconstruction with radiotherapy.
BACKGROUND: Postmastectomy radiotherapy may adversely affect breast reconstructive outcomes. However, the comparative effect of radiotherapy on direct-to-implant versus tissue expander-implant reconstruction has not been examined.
METHODS: Single institution retrospective review was performed and patients were followed 2 to 10 years.
RESULTS: Of 1566 patients, 265 patients received radiation (149 immediate implants and 116 tissue expanders). Demographics were similar except more smokers in the expander group (7.7% vs 1.3%; P = 0.012). Patients who received radiation with an expander in place had overall more complications (32.8% vs 11.4%; P < 0.001), skin necrosis (10.3% vs 4.0%; P = 0.043), wound breakdown (9.5% vs 2.7%; P = 0.029), and infections (16.4% vs 4.03%; P = 0.001) leading to a higher rate of explantation (16.4% vs 4.0%; P < 0.001). A radiation boost likewise predicted complications [odds ratio (OR) 2.199, 95% confidence interval (CI) 1.154-4.188, P = 0.017]. When comparing reconstructive outcomes, radiated expanders had a higher failure rate (21.6% vs 11.4%; P = 0.025). Revision for capsular contracture was similar between the 2 cohorts (11.4% vs 11.2%; P = 0.959) as were revision rates for contour asymmetry and breast asymmetry. In our multivariable logistic regression analysis, radiation to the expander had a higher risk of reconstruction failure than radiation to the permanent implant (OR 2.020, 95% CI 1.010-4.037, P = 0.047).
CONCLUSION: Most patients had successful implant-based reconstructions after mastectomy and radiotherapy. Our study showed radiotherapy after direct-to-implant breast reconstruction had a lower rate of complications and reconstructive failure compared to tissue expander-implant reconstruction.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 31714307     DOI: 10.1097/SLA.0000000000003670

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

Review 1.  Radiation-Induced Tissue Damage: Clinical Consequences and Current Treatment Options.

Authors:  Hillary Nepon; Tyler Safran; Edward M Reece; Amanda M Murphy; Joshua Vorstenbosch; Peter G Davison
Journal:  Semin Plast Surg       Date:  2021-09-10       Impact factor: 2.195

2.  Is Tissue Expansion Worth It? Comparative Outcomes of Skin-preserving versus Delayed Autologous Breast Reconstruction.

Authors:  Brett T Phillips; Genevieve Mercier-Couture; Amy S Xue; Carrie K Chu; Mark V Schaverien; Jun Liu; Patrick B Garvey; Donald P Baumann; Charles E Butler; Rene D Largo
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-11-24

3.  Short-Term Surgical Complications of Skin-Sparing Mastectomy and Direct-to-Implant Immediate Breast Reconstruction in Women Concurrently Treated with Adjuvant Radiotherapy for Breast Cancer.

Authors:  Merel M L Kooijman; J Joris Hage; Astrid N Scholten; Marie-Jeanne T F D Vrancken Peeters; Leonie A E Woerdeman
Journal:  Arch Plast Surg       Date:  2022-05-27

4.  Analysis of Secondary Surgeries after Immediate Breast Reconstruction for Cancer Compared with Risk Reduction.

Authors:  Stacey J Jones; Philip Turton; Rajgopal Achuthan; Brian V Hogan; Shireen N Mckenzie; Baek Kim
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-12-17

5.  Early Expander-to-Implant Exchange after Postmastectomy Reconstruction Reduces Rates of Subsequent Major Infectious Complications.

Authors:  Jean-Claude D Schwartz
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-12-18

6.  Quality of life and patient satisfaction after implant-based breast reconstruction with or without acellular dermal matrix: randomized clinical trial.

Authors:  F Lohmander; J Lagergren; H Johansson; P G Roy; J Frisell; Y Brandberg
Journal:  BJS Open       Date:  2020-08-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.